From: Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma
Variable | n = 88 (range, %) | Missing data, n (%) |
---|---|---|
Staging laparoscopy | 78 (89) | 0 (0) |
Type of surgery | Â | 0 (0) |
 Left hepatectomy | 29 (33) |  |
 Right hepatectomy | 26 (30) |  |
 Central hepatectomy | 4 (5) |  |
 Extended left hepatectomy | 2 (2) |  |
 Extended right hepatectomy | 2 (2) |  |
 Bile duct resection | 23 (26) |  |
 Segmental hepatectomy and bile duct resection | 2 (2) |  |
Caudate lobe resection | 56 (64) | 0 (0) |
Common hepatic artery resection | 3 (3) | 0 (0) |
Portal vein resection | 18 (20) | 0 (0) |
Duration of surgery (minutes, median, range) | 240 (140–360) | 62 (71) |
Intraoperative blood loss (mL, median, range) | 900 (50–12000) | 47 (53) |
Intraoperative transfusion | 38 (43) | 0 (0) |
Pringle manoeuvre performed | 8 (9) | 1 (1) |
 Total duration (minutes, median, range) | 25 (10–45) | 2 (2) |
Intraoperative complication | 20 (23) | 0 (0) |
Postop ICU admission | 16 (18) | 0 (0) |
 Length of ICU stay (days, median, range) | 4 (1–13) | 0 (0) |
TOSGS > 2 (excl. mortality) | 33 (38) | 0 (0) |
Postoperative haemorrhage | Â | 0 (0) |
 ISGLS grade B | 5 (6) |  |
 ISGLS grade C | 5 (6) |  |
Liver failure | Â | 0 (0) |
 ISGLS grade A | 1 (1) |  |
 ISGLS grade B | 2 (2) |  |
 ISGLS grade C | 5 (6) |  |
Bile leak | Â | 0 (0) |
 ISGLS grade A | 2 (2) |  |
 ISGLS grade B | 18 (21) |  |
 ISGLS grade C | 5 (6) |  |
Postoperative blood transfusion | 34 (39) | 0 (0) |
Postoperative complications | Â | 0 (0) |
 Intra-abdominal abscess | 25 (28) | 0 (0) |
 Sepsis | 5 (6) |  |
 Portal thrombosis | 4 (5) |  |
 Pulmonary complication | 12 (14) |  |
 Cardiac complication | 4 (4) |  |
 Multiple organ failure | 4 (4) |  |
Reoperation | 13 (15) | 0 (0) |
In-hospital mortality | 8 (9) | 0 (0) |
90-day mortality | 8 (9) | 0 (0) |
Length of hospital stay (days, median, range) | 18 (3–94) | 0 (0) |
Readmission within 30 days of discharge | 12 (14) | 0 (0) |
Any recurrence | 42 (48) | Â |
Locoregional recurrence | 18 (21) | 0 (0) |
Location of first metastatic recurrence | 39 (44) | 0 (0) |
 Liver | 13 (15) |  |
 Peritoneum | 12 (14) |  |
 Pulmonary | 3 (3) |  |
 Retroperitoneal lymph nodes | 6 (7) |  |
 Pancreas | 2 (2) |  |
 Abdominal wall muscle | 2 (2) |  |
 Colon | 1 (1) |  |